← FDA Drug Approvals (Drugs@FDA)

OPUVIZ

BLA · Biologics License Application · Sponsor: SAMSUNG BIOEPIS CO LTD · Approved 2024-05-20

Drug application

FDA Application #

BLA761350

Application type

Biologics License Application

Brand name

OPUVIZ

Generic name

Aflibercept-Yszy

Active ingredients

AFLIBERCEPT-YSZY

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SAMSUNG BIOEPIS CO LTD

First approval

2024-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown